AWARE: Managing ADHD in Autism Spectrum Disorder
Phase 4
500
about 4.2 years
4–17
10 sites in CA, MA, ME +4
What this study is about
This trial is testing two different types of stimulant medication and an alpha-2 agonist to see which works best for children with both ADHD and autism. The goal is to help doctors choose the right treatment more effectively, reducing the need for repeated trials of multiple medications.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant
- 2.Take Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
NERVOUS SYSTEM, stimulant (CNS stimulant; blocks reuptake of dopamine and norepinephrine)
oral (Disintegrating Oral Tablet)
Psychiatry / Mental Health